Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Vaginal surgeries generally did not significantly change women's sexual quality of life.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

The study identifies four distinct zones in the fetal vaginal epithelium, enhancing understanding for potential applications in women's health.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Low estrogen due to poor nutrition can lead to non-alcoholic fatty liver disease.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.